Mitralign's Series F Round

Mitralign raised a round of funding on February 20, 2018.

Mitralign is developing a catheter-based technology for percutaneous treatment of functional mitral regurgitation. The Mitralign system emulates surgical annuloplasty delivering a series of surgical i…

Articles about Mitralign's Series F Round: